Brownstone Design in Cambridge

Log in
updated 2:01 AM BST, Jul 25, 2014
Technology and life sciences news from the Cambridge cluster

Windows giveth, Android taketh away for Arm, Domino and Abcam warn on growth prospects

  • Written by Ben Fountain
  • Published in The Cluster
A screenshot from Windows 8 - unveiled at a developer preview earlier this weekA week of swings and roundabouts for Arm, with the warm glow engendered by the unveiling of an Arm-compatible Windows 8 operating system tempered somewhat by news - announced on the same day - that Google is optimising its Android mobile operating system for Intel chips.

While Arm’s deal with Microsoft has been priced in for some time, the increased competition on Android has not. The market didn’t seem unduly concerned though, with Arm’s shares up 3.19 per cent for the week. An Espirito Santo Investment Bank research note - as reported by Fox Business - summed up market sentiment: "We remain skeptical of Intel's ability to gain share and be a major threat to ARM in the mobile space in the near term."

Domino Printing was a shade over 11 per cent down today to 499.6 p, 9.5 per cent for the week, after it warned of softening demand for new equipment in Western Europe and North America.

The industrial printing company said in an interim management statement that although sales for the ten months to the end of August were four per cent up on last year, they were one per cent down over the past four months. “It is not yet clear whether the recent slowing in activity levels is a short term effect caused by current general negative economic sentiment, or is signalling a longer term slowdown in capital spend.  We are restricting incremental costs until the situation becomes clearer,” Domino said in the statement.

The statement also gave an update on the company’s $50m investment in TEN Media, an egg coding specialist. Domino said it expects the first financial returns from the investment to start in Q2 of its next financial year.

Online research product supplier, Abcam also sounded a note of caution this week, albeit in the same breath as the announcement of a £10m acquisition, an increase in dividend and a large increase in profits.

Chairman, Michael Redmond said: "For several years we have cautioned that the way in which Western governments adjust their spending patterns may affect our business.

"It is apparent that it is not only actual reductions that have an impact on researchers' spending, but the threat of cuts can be sufficient to cause a reaction as well."

Abcam said it is attempting to address this by moving into fields adjacent to its core antibodies market under the wider umbrella of protein research.

Process technology company, PDX announced another in a seemingly regular stream of minor breakthroughs yesterday - a £400k contract to supply a system to “one of Europe’s leading food producers.” CEO Roel Pieper said the contract demonstrated the value of PDX’s technology to the food and beverage market.

PDX shares are down well over 50 per cent since the beginning of the year, but close out this week 6.42 per cent up to 212p as the company continues to chip away at its key target markets.

Speaking of which, RFID company Ubisense added new strings to its bow this week, with announcements that the company’s real time location technology was being used in research into Alzheimer’s and also at a trade show to pin-point the relevant expertise within an exhibiting company when customers come calling at the booth.